Stocks Amgen Inc

More

  • BlackRock vice chairman and global chief investment officer of equities Bob Doll says it's time to re-introduce risk into portfolios.

  • The week ended with a stunningly bad November jobs report, indicating that the economy is getting much worse much faster than expected, and suggesting that the recession will be especially deep and prolonged.   It was a grim end to a volatile week, beginning with a huge loss on Monday, but CNBC guests continued to encourage investors to buy stocks, saying now is the time to position oneself for the recovery and take advantage of valuations.

  • The stock market was far off its morning lows, coming close to turning positive, as investors shook off a handful of weak economic reports and snapped up biotech shares and other defensive plays.

  • pharma_new2.jpg

    Look for M&A activity—big and small—a pair of breakthrough drugs and the prospect of government price controls.

  • The Thanksgiving-week rally took the markets up 10 percent, and with a 28-percent gain, financials outperformed just about everything else.  BlackRock's Bob Doll sees investors cashing in on those gains this week, and recommends a move to more defensive stocks.

  • One of the weapons widely used to fight cholesterol might be more powerful than previously believed. Is there a trade here?

  • AMGEN

    While on the elliptical at the gym the other night I was watching one network newscast and the person on the machine next to me was watching another one.

  • webxtra_thumb.jpg

    In this Web Extra find out why investors who are attempting to battle the bear with biotech are keeping a close eye on Amgen..

  • graphic_word_ofthe_street.jpg

    Stocks clawed back from five-year lows on Thursday, led by a bounce in energy and health-care stocks...

  • Stocks made a third attempt at a rally Thurdsay though techs took a beating amid worries about the outlook for the sector.

  • A rally spurred by bargain hunting fizzled Thursday as weakness in technology leaders offset strength energy-related companies.

  • Stocks wavered after an early pop Thursday as the latest batch of earnings and a disappointing weekly jobless report stoked recession fears.

  • U.S. stocks opened slightly higher despite worse-than-expected weekly jobless numbers and growing recession fears.

  • graphic_word_ofthe_street.jpg

    The Dow made another triple digit move on Monday this time soaring more than 400 points higher.

  • webxtra_thumb.jpg

    Despite a slowing economy, drug stocks such as Abbott Labs and Genentech posted positive earnings reports. Is health care the best defensive play in this market?

  • FFF_Fast_Furious_Thumb.jpg

    Following are the “Fast & Furious” trades - hot ways to play next week's market moving events.

  • As the Dow, S&P and NASDAQ chalk up some of the biggest weekly losses ever, how does that translate to dollar terms?

  • Even in the worst of times, don't give up on stocks.

  • Amgen

    This morning the world's biggest biotech company released the highly-anticipated detailed test results on its crucial, late-stage experimental osteoporosis drug known as D-mab. And they look good.